mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.7 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |